Impaired endothelial function in never-treated hypertensive subjects carrying the Arg972 polymorphism in the insulin receptor substrate-1 gene

The Journal of Clinical Endocrinology and Metabolism
Francesco PerticoneGiorgio Sesti

Abstract

Some cardiovascular risk factors, such as hypertension and insulin resistance, are associated with endothelial dysfunction. Insulin regulates both in vitro and in vivo expression of endothelial nitric oxide synthase (eNOS) via a pathway involving insulin receptor substrate-1 (IRS-1) and phosphatidylinositol-3 kinase. Recently, we found that human endothelial cells obtained from carriers of the Arg(972) IRS-1 polymorphism exhibited reduced eNOS expression in response to chronic exposure to insulin. A reduction in eNOS expression would be expected to be associated with impaired endothelium-dependent vasodilation. To investigate a possible relationship between Arg(972) IRS-1 polymorphism and endothelial dysfunction in vivo, we enrolled a cohort of 100 never-treated hypertensive subjects. Endothelium-dependent and endothelium-independent vasodilation were assessed by increasing doses of acetylcholine and sodium nitroprusside. IRS-1 polymorphism was detected by PCR. The allelic frequency of the Arg(972) IRS-1 variant was 8.0%. Stratifying subjects according to IRS-1 genotype, we observed that acetylcholine-stimulated forearm blood flow was significantly (P < 0.0001) lower in Gly/Arg heterozygous carriers than in Gly/Gly carriers (11...Continue Reading

Citations

Jan 12, 2013·Reviews in Endocrine & Metabolic Disorders·Ranganath Muniyappa, James R Sowers
Jan 27, 2012·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Hongmei LiYonghong Zhang
Jun 17, 2011·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Joanna DziwuraKrystyna Widecka
Feb 3, 2005·Current Opinion in Nephrology and Hypertension·Yoram Yagil, Chana Yagil
Feb 17, 2006·Current Opinion in Nephrology and Hypertension·Martin W McBrideAnna F Dominiczak
Oct 9, 2007·Journal of Hypertension·Francesco PerticoneDaniele Cusi
Dec 4, 2012·International Journal of Molecular Sciences·Angela SciacquaFrancesco Perticone
Mar 11, 2011·Acta Diabetologica·Carina TörnUNKNOWN DISS study group
Aug 19, 2009·Archives of Physiology and Biochemistry·Giovanni AnfossiMariella Trovati
Oct 18, 2005·Alimentary Pharmacology & Therapeutics·M Federici, R Lauro
Mar 31, 2016·International Journal of Molecular Sciences·Maria PerticoneFrancesco Perticone
Jan 21, 2015·Toxicological Sciences : an Official Journal of the Society of Toxicology·You-Jin ChoiByung-Hoon Lee
Dec 20, 2011·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·T MontalciniA Pujia
Jun 9, 2017·Thrombosis and Haemostasis·Georg BreierEmilio Hirsch
Apr 26, 2008·Arteriosclerosis, Thrombosis, and Vascular Biology·Francesco AndreozziGiorgio Sesti
May 26, 2007·Endocrine Reviews·Ranganath MuniyappaMichael J Quon
Nov 27, 2014·International Journal of Rheumatic Diseases·Hongjun ZhaoYunhui You
Jan 27, 2009·International Journal of Cardiology·Francesco PerticoneGiorgio Sesti

❮ Previous
Next ❯

Related Concepts

Related Feeds

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.